Trials / Conditions / Stage IIIC Vulvar Cancer AJCC v7

Stage IIIC Vulvar Cancer AJCC v7

3 registered clinical trials studyying Stage IIIC Vulvar Cancer AJCC v7.

Status	Trial	Sponsor	Phase
Withdrawn	Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High NCT03220009	National Cancer Institute (NCI)	Phase 2
Completed	Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage II NCT01406769	Gynecologic Oncology Group	Phase 2
Unknown	Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamou NCT01595061	Gynecologic Oncology Group	Phase 2